Tranexamic Acid During Upper GI Endoscopic Resection Procedures
Gastric Polyp, Gastric Neoplasm, Duodenal Neoplasms
About this trial
This is an interventional prevention trial for Gastric Polyp
Eligibility Criteria
Inclusion Criteria: Patients referred for endoscopic resection of a non-neoplastic and neoplastic lesions in the upper GI presenting to our tertiary academic center. Age > 18 years Exclusion Criteria: patients with histories of allergic reactions to TXA history of seizures pregnancy
Sites / Locations
- Shamir Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Tranexamic acid
Epinephrine
During the ER procedure, de-identified injectate solution will be introduced. Study group: 9 ml of standart solution for injection [Consisit of: 6 ml indigo carmine + 500 ml succinylated gelatin 4% (Gelofusine; B. Braun, Crissier, Switzerland)] + 1 ml (100mg) of TXA (tranexamic acid).
During the ER procedure, de-identified injectate solution will be introduced. 9 ml of standart solution for injection [Consisit of: 6 ml indigo carmine + 500 ml succinylated gelatin 4% (Gelofusine; B. Braun, Crissier, Switzerland)] + 1 ml epinephrine 1:100,000 + 1 ml saline 0.9%.